Facundo Bagnis Accepts One-Year Suspension Following Positive Doping Test

Argentine tennis player Facundo Bagnis has accepted a one-year suspension after testing positive for hydrochlorothiazide, a banned diuretic, during the 2023 US Open. The sanction, which stems from a finding of an “unintentional infringement,” will see the athlete sidelined from professional competition until October.

Details of the Positive Test and Suspension

The positive test occurred during the hard-court season in New York. Following the notification of the adverse analytical finding, investigations were conducted to determine the origin of the substance.

According to reports, the investigation confirmed that the presence of the banned substance was the result of a contaminated supplement. This finding of unintentional ingestion was central to the ruling, as it allowed for a reduction in what could have been a more severe or multi-year ban. By accepting the one-year term, Bagnis opted to conclude the disciplinary process without further litigation.

The Impact of Supplement Contamination in Tennis

Timeline for Return to Competition

With the suspension set to expire in October, Bagnis is currently in the final stages of his forced hiatus.

Next Steps for the Argentine Player

Once the October date arrives, he will be eligible to resume training and competition at all levels of professional tennis.